Daily FNArena News - Australia

A wrap of the day’s activity on the Australian stock market.

Premier Investments impressed brokers with sales growth across all brands in FY14 but a repeat performance in FY15 may be difficult.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

A wrap of the day’s activity on the Australian stock market.

A wrap of the day’s activity on the Australian stock market.

Macquarie has signalled a step-up in performance fees in FY15 but most brokers are looking for signs of improvement in the bigger picture as well.

With little end in sight to a weak iron ore price, Arrium has decided to act upon its debt sooner rather than later by announcing a surprise raising. Brokers discuss whether investors should take up their rights.

CSL’s competitor, Baxter, has received US FDA approval for HyQvia and brokers assess the impact on CSL’s rival product, Hizentra.

A wrap of the day’s activity on the Australian stock market.